As healthcare professionals, we are witnessing an alarming increase in obesity rates worldwide. This rise is accompanied by a surge in associated comorbidities like type 2 diabetes, cardiovascular diseases, and certain types of cancer. Hence, it is crucial to explore effective strategies for managing obesity.
Behavioral interventions form the cornerstone of obesity management. They involve dietary modifications, physical activity enhancement, and behavioral changes. These interventions can be delivered individually or in groups, face-to-face or remotely. The key is to customize the approach based on patient's needs and preferences.
Pharmacotherapy can be considered in patients with a BMI ≥30 or ≥27 with comorbidities, who have not responded to behavioral interventions. The choice of drug should be guided by the patient's comorbid conditions, potential side effects, and cost. Regular follow-up is essential to monitor efficacy and adverse effects.
Endoscopic and surgical interventions are reserved for patients with severe obesity (BMI ≥40 or ≥35 with comorbidities) who have not responded to non-surgical strategies. While these methods have shown significant weight loss and improvement in comorbid conditions, they are associated with potential complications and require lifelong medical follow-up.
Managing obesity requires an interdisciplinary approach involving dietitians, exercise physiologists, behavioral therapists, pharmacists, and surgeons. This team-based approach ensures comprehensive care, addressing all aspects of obesity.
Obesity management is a complex, multifaceted process requiring a personalized, patient-centered approach. It involves behavioral interventions, pharmacotherapy, endoscopic or surgical interventions, and an interdisciplinary team approach. As healthcare professionals, we need to stay updated with the latest evidence-based strategies to provide optimal care to our patients with obesity.
1.
Rural colon cancer patients face higher risks, but minimally invasive surgery could narrow gap
2.
Chemotherapy before surgery helps patients with nose and sinus cancer avoid debilitating eye and bone removal
3.
Laryngeal Transplant Helped a Cancer Patient Speak Again in Pioneering Study
4.
The amount of liver tissue removed during gallbladder surgery has no discernible impact on overall survival.
5.
Long-Acting Interferon Therapy Approved for ET
1.
Molecular Network Mapping in Hematologic Disease
2.
Metabolic Reprogramming of the Tumor Microenvironment: Mechanisms, Clinical Relevance, and Emerging Therapeutic Strategies
3.
Hematopoietic Stem Cell Clonal Dynamics Across the Lifespan
4.
Connected Hematology Laboratory Networks for Automated Cross-Institution Data Exchange
5.
Digital Oncology Ecosystems Integrating Longitudinal Patient Trajectories: Transforming Cancer Care through Data-Driven Innovation
1.
International Conference on Innovations in Critical Care for Oncology and Cardiology
2.
International Conference on Oncology, Cardiology and Critical Care Policy
3.
International Conference on Oncology, Cancer Prevention and Public Health
4.
International Conference on Cancer Nursing and Rehabilitation Strategies
5.
International Conference on Best Practices in Oncology, Cardiology and Critical Care
1.
Breaking Ground: ALK-Positive Lung Cancer Front-Line Management - Part V
2.
Common side effects of cancer treatment and how they are managed
3.
Clinical Excellence in Hematology
4.
Best Practices in Hematology
5.
Current Scenario of Blood Cancer- Further Discussion on Genomic Testing & Advancement in Diagnosis and Treatment
© Copyright 2026 Hidoc Dr. Inc.
Terms & Conditions - LLP | Inc. | Privacy Policy - LLP | Inc. | Account Deactivation